Lamontagne F, Masse M, Yarnell C, Camirand-Lemyre F, Levesque S, Domingue M
CMAJ. 2024; 196(23):E779-E788.
PMID: 38885975
PMC: 11182674.
DOI: 10.1503/cmaj.230760.
Berdel W
Cancers (Basel). 2022; 14(5).
PMID: 35267614
PMC: 8909270.
DOI: 10.3390/cancers14051308.
Tsutsumi I, Tsutsumi Y, Yoshida C, Komeno T, Imanaka Y
J Epidemiol. 2021; 32(1):27-33.
PMID: 34690242
PMC: 8666319.
DOI: 10.2188/jea.JE20210051.
Olsen M, Hansen M, Safi S, Jakobsen J, Greisen G, Gluud C
BMC Med Res Methodol. 2021; 21(1):160.
PMID: 34332547
PMC: 8325420.
DOI: 10.1186/s12874-021-01344-4.
Mentzelopoulos S, Couper K, Van de Voorde P, Druwe P, Blom M, Perkins G
Notf Rett Med. 2021; 24(4):720-749.
PMID: 34093076
PMC: 8170633.
DOI: 10.1007/s10049-021-00888-8.
Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review.
Cragg W, Hurley C, Yorke-Edwards V, Stenning S
Clin Trials. 2021; 18(2):245-259.
PMID: 33611927
PMC: 8010889.
DOI: 10.1177/1740774520976561.
Institutional work to maintain, repair, and improve the regulatory regime: How actors respond to external challenges in the public supervision of ongoing clinical trials in the Netherlands.
van Oijen J, Wallenburg I, Bal R, Grit K
PLoS One. 2020; 15(7):e0236545.
PMID: 32735568
PMC: 7394415.
DOI: 10.1371/journal.pone.0236545.
Making consent for electronic health and social care data research fit for purpose in the 21st century.
Heslop P, Davies K, Sayer A, Witham M
BMJ Health Care Inform. 2020; 27(1).
PMID: 32616478
PMC: 7333808.
DOI: 10.1136/bmjhci-2020-100128.
Low-risk trials for children and pregnant women threatened by unnecessary strict regulations. Does the coming EU Clinical Trial Regulation offer a solution?.
Knaapen M, Ploem M, Kruijt M, Oudijk M, van der Graaf R, Bet P
Eur J Pediatr. 2020; 179(8):1205-1211.
PMID: 32535715
PMC: 7351802.
DOI: 10.1007/s00431-020-03715-3.
Challenges of international oncology trial collaboration-a call to action.
Tang M, Joensuu H, Simes R, Price T, Yip S, Hague W
Br J Cancer. 2019; 121(7):515-521.
PMID: 31378784
PMC: 6889481.
DOI: 10.1038/s41416-019-0532-4.
Methodological challenges in European ethics approvals for a genetic epidemiology study in critically ill patients: the GenOSept experience.
Tridente A, Holloway P, Hutton P, Gordon A, Mills G, Clarke G
BMC Med Ethics. 2019; 20(1):30.
PMID: 31064358
PMC: 6503539.
DOI: 10.1186/s12910-019-0370-1.
Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN).
Madeira C, Pais A, Kubiak C, Demotes J, Monteiro E
Contemp Clin Trials Commun. 2018; 4:141-148.
PMID: 29736477
PMC: 5935898.
DOI: 10.1016/j.conctc.2016.08.002.
What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK.
Duley L, Gillman A, Duggan M, Belson S, Knox J, McDonald A
Trials. 2018; 19(1):15.
PMID: 29310685
PMC: 5759880.
DOI: 10.1186/s13063-017-2378-5.
Which Obstacles Prevent Us from Recruiting into Clinical Trials: A Survey about the Environment for Clinical Studies at a German University Hospital in a Comprehensive Cancer Center.
Straube C, Herschbach P, Combs S
Front Oncol. 2017; 7:181.
PMID: 28894695
PMC: 5581318.
DOI: 10.3389/fonc.2017.00181.
Towards the development of a comprehensive framework: Qualitative systematic survey of definitions of clinical research quality.
von Niederhausern B, Schandelmaier S, Bonde M, Brunner N, Hemkens L, Rutquist M
PLoS One. 2017; 12(7):e0180635.
PMID: 28715491
PMC: 5513422.
DOI: 10.1371/journal.pone.0180635.
Comparative costs and activity from a sample of UK clinical trials units.
Hind D, Reeves B, Bathers S, Bray C, Corkhill A, Hayward C
Trials. 2017; 18(1):203.
PMID: 28464930
PMC: 5414193.
DOI: 10.1186/s13063-017-1934-3.
"You can save time if…"-A qualitative study on internal factors slowing down clinical trials in Sub-Saharan Africa.
Vischer N, Pfeiffer C, Limacher M, Burri C
PLoS One. 2017; 12(3):e0173796.
PMID: 28301530
PMC: 5354381.
DOI: 10.1371/journal.pone.0173796.
Input analysis for two public consultations on the EU Clinical Trials Regulation.
Langhof H, Lander J, Strech D
Health Res Policy Syst. 2016; 14(1):69.
PMID: 27639695
PMC: 5027082.
DOI: 10.1186/s12961-016-0141-0.
Promoting good health research practice in low- and middle-income countries.
Mahendradhata Y, Nabieva J, Ahmad R, Henley P, Launois P, Merle C
Glob Health Action. 2016; 9:32474.
PMID: 27498965
PMC: 4976305.
DOI: 10.3402/gha.v9.32474.
Finding Alternatives to the Dogma of Power Based Sample Size Calculation: Is a Fixed Sample Size Prospective Meta-Experiment a Potential Alternative?.
Tavernier E, Trinquart L, Giraudeau B
PLoS One. 2016; 11(6):e0158604.
PMID: 27362939
PMC: 4928786.
DOI: 10.1371/journal.pone.0158604.